by Admin | Feb 7, 2024
Areterna offers Cap Analogs, NTPs, and Modified NTPs for mRNA synthesis. Our products have been tested and accepted by over 200 companies worldwide. One of these companies shared with us how they decided to use our products.
by May Guo | Jan 17, 2024
We discussed our novel cap analogs, CAP4 and CAP5, in the last blog The Evolution of Cap Analogs, you may wonder how we discovered these unique molecules. Areterna’s engine of innovation is built upon our AI-Assisted Cap Analog Discovery Platform which integrates a...
by May Guo | Dec 28, 2023
Introduction In the intricate world of mRNA synthesis, the cap structure plays a pivotal role in regulating gene expression. Scientists have made significant strides in the development of various cap analogs to enhance mRNA stability, translational efficiency, and...
